Eculizumab and Splenectomy as Salvage Therapy for Severe Antibody-Mediated Rejection After HLA–Incompatible Kidney Transplantation

Title
Eculizumab and Splenectomy as Salvage Therapy for Severe Antibody-Mediated Rejection After HLA–Incompatible Kidney Transplantation
Authors
Keywords
-
Journal
TRANSPLANTATION
Volume 98, Issue 8, Pages 857-863
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2014-08-14
DOI
10.1097/tp.0000000000000298

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started